Organon counts on PAS-X for API production

Published: 18-Jan-2007
Manufacturing

Organon, the human healthcare business unit of Akzo Nobel, has finished the installation of Germany-based Werum Software & Systems' PAS-X MES software in their new state-of-the-art API-powder processing production facility in Oss, Netherlands.


Organon, the human healthcare business unit of Akzo Nobel, has finished the installation of Germany-based Werum Software & Systems' PAS-X MES software in their new state-of-the-art API-powder processing production facility in Oss, Netherlands.

Mixing and milling as well as a final-product warehouse were combined in this new factory. Organon uses PAS-X for recipe management, weighing and dispensing, shop floor management, electronic batch recording, and warehouse management. Throughout all the manufacturing processes PAS-X has replaced paper-based recipes and SOPs by electronic records. Operators get information about the production processes on screen, and are also able to give feedback about process parameters by computer.

  • Companies:
  • Nouryon
See more

You may also like

Manufacturing

Improving healthcare has led to a higher salt requirement

Read more
The number of dialysis treatments is increasing across the globe, mainly due to an increasing number of patients and improved healthcare in many developing countries

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. ChargePoint invest in a single-use manufacturing facility to expand product line The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
  3. Innovation in generics: increased efficiency through peptide API synthesis expertise Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
  4. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  5. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be complicated. Here, the tablet experts Natoli explain how to develop tabletability, compactibility, and compressibility profiles

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Manufacturing

Improving healthcare has led to a higher salt requirement

The number of dialysis treatments is increasing across the globe, mainly due to an increasing number of patients and improved healthcare in many developing countries
Training & Education

AkzoNobel helps develop next generation of skilled workers

The company's commitment to inspiring young minds will be recognised in the Employer of the Year category of the inaugural Industrial Cadets Awards
Manufacturing

Innovation in generics: increased efficiency through peptide API synthesis expertise

Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
Manufacturing

For easy transition from glass to plastic accessories - BOLA components with GL threads

The GL thread is the most common thread on lab equipment made of glass. Available from Labtex in the UK, BOLA offers a modular construction system with many different components with GL threads
Distribution

ChargePoint invest in a single-use manufacturing facility to expand product line

The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Manufacturing

Optimising RNA production for faster and cheaper pharmaceutical manufacturing

RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the avoidance of scaling issues
Manufacturing

Memel Biotech and Therabest collaborate to develop exosome-based cell therapies

The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Subscribe now